Skip to main content
Clinical Trial Compass
Back to search

Acute Myeloid Leukemia With Flt3 Activating Mutations That Has Relapsed Or Been Refractory After One Or More Prior Therapies

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acute Myeloid Leukemia With Flt3 Activating Mutations That Has Relapsed Or Been Refractory After One Or More Prior Therapies trials may be worth asking about